Home › Funds › Exome Asset Management LLC › NBP

Exome Asset Management LLC position in NBP

NOVABRIDGE BIOSCIENCES · Health Care

Exome Asset Management LLC reported holding 576,960 shares of NBP (NOVABRIDGE BIOSCIENCES) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 0.69% of its reported portfolio and ranking #45 among its reported holdings. Exome Asset Management LLC has disclosed NBP holdings in 6 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)576.96K sh
Reported value held$1.13M
Portfolio Weight0.69%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Exome Asset Management LLC's NBP position evolved

Exome Asset Management LLC first disclosed a stake in NBP in Q1 2024 at 325,762 shares (US$606K). The position peaked in Q3 2025 at 1,439,604 shares, worth US$5.4M. Across 6 filings, Exome Asset Management LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 576,960 shares valued at US$1.1M. Notable position changes include a 65% trim in Q4 2025 (shares fell 39% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 325.76K $605.92K New
Q2 2024 271.40K $453.24K Reduce
Q3 2025 1.44M $5.44M New
Q4 2025 499.59K $1.99M Reduce
Q1 2026 576.96K $1.42M Add
Q2 2026 576.96K $1.13M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBP and 13F data

NBP (NOVABRIDGE BIOSCIENCES) is a Health Care company. 30 other funds we track also report a position in NBP — the largest reported positions include Hillhouse Capital (HHLR Advisors) (US$11.7M), AIHC Capital Management Ltd (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBP

All NBP fund holders →

FAQ

How long has Exome Asset Management LLC held NBP?

Exome Asset Management LLC has disclosed NBP holdings in 6 of the last 10 reported quarters, going back to Q1 2024.

What is Exome Asset Management LLC's current position in NBP?

As of Q2 2026, Exome Asset Management LLC holds 576.96K shares of NBP (NOVABRIDGE BIOSCIENCES), valued at $1.13M, representing 0.69% of its reported portfolio and ranking #45.

Has Exome Asset Management LLC been buying or selling NBP?

In the latest 13F filing (Q2 2026), Exome Asset Management LLC held unchanged its position in NBP. The position peaked in Q3 2025 at 1.44M shares.

Which other funds hold NBP?

Other major institutional holders of NBP include Hillhouse Capital (HHLR Advisors), AIHC Capital Management Ltd, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.